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ABSTRACT
Objectives: To describe how adverse event (AE) rates
were monitored and estimated nationally across all
Norwegian hospitals from 2010 to 2013, and how they
developed during the monitoring period. Monitoring
was based on medical record review with Global
Trigger Tool (GTT).
Setting: All publicly and privately owned hospitals
were mandated to review randomly selected medical
records to monitor AE rates. The initiative was part of
the Norwegian patient safety campaign, launched by
the Norwegian Ministry of Health and Care Services.
It started in January 2011 and lasted until December
2013. 2010 was the baseline for the review. One of the
main aims of the campaign was to reduce patient
harm.
Method: To standardise the medical record reviews in
all hospitals, GTT was chosen as a standard method.
GTT teams from all hospitals reviewed 40 851 medical
records randomly selected from 2 249 957 discharges
from 2010 to 2013. Data were plotted in time series for
local measurement and national AE rates were
estimated, plotted and monitored.
Results: AE rates were estimated and published
nationally from 2010 to 2013. Estimated AE rates in
severity categories E-I decreased significantly from
16.1% in 2011 to 13.0% in 2013 (−3.1% (95% CI
−5.2% to −1.1%)).
Conclusions: Monitoring estimated AE rates emerges
as a potential element in national systems for patient
safety. Estimated AE rates in the category of least
severity decreased significantly during the first 2 years
of the monitoring.
INTRODUCTION
Based on several studies,1–5 the WHO has
estimated that about 10% of patients are
harmed in relation to hospital care in
Western countries.6 7 This has created
momentum for large-scale interventions in
many countries.8 9 To facilitate monitoring of
adverse events (AEs) within reasonable use
of resources, the Institute for Healthcare
Improvement (IHI) developed Global
Trigger Tool (GTT) as a standard tool.9 10
The GTT deﬁnition of an AE is: “unintended
physical injury resulting from or contributed
to by medical care that requires additional
monitoring, treatment or hospitalisation, or
results in death”. Studies that used GTT in
major US hospitals found AE rates of 27.7%
and 33.2%.11 12 The GTT deﬁnition is at
variance with the WHO deﬁnition, which
may explain some of the discrepancy from
the WHO estimate.
A research scan from the Health
Foundation has considered GTT to compare
well to other approaches, to be relatively sen-
sitive and to identify signiﬁcantly more AEs
compared with self-reporting or other chart
audit approaches. Most of the studies
describing its use are based on large samples
from multiple hospitals. Although the GTT is
considered relevant for measuring harm at
national level, few studies describe the
process of doing so.13 14
The Norwegian Ministry of Health and
Care Services mandated all publicly and pri-
vately owned hospitals to review randomly
selected medical records from 2010. GTT was
chosen as a standard method in order to be
able to aggregate results. The review started
on medical records from March 2010 to
make a baseline. Results have been published
in annual reports since 2011 (for 2010–
2013).15 Hospitals plotted data in diagrams
on a web-based tool, facilitated by IHI, called
Extranet, together with an additional
Strengths and limitations of this study
▪ The study covers, with few exceptions, all pub-
licly and privately owned hospitals in Norway.
▪ The study is based on reviews of 40 851 hospital
discharges.
▪ The Global Trigger Tool (GTT) reviewer teams
applied the same standards and had the same
training.
▪ The reviews were done by many teams and not
only by one, which increases variability in results
related to discretion.
▪ The size of reviewed samples was the same inde-
pendent of hospital size.
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p-control chart tool. This has enabled them to follow
and analyse their own results with statistical process
control. The initiative from the health authorities was
part of the planned national patient safety campaign,
called ‘In Safe Hands’, which was launched in January
2011. The campaign aimed to reduce harmful events to
patients, to establish competence and hospital routines
for patient safety and to improve patient safety culture.
The aim of this study is to describe how the GTT
method was applied at national level for monitoring
AEs, and how the estimates developed during the moni-
toring period.
METHODS
Setting and inclusion criteria
All 19 publicly owned hospitals in Norway participated
in the 2011 and 2012 reviews. Some of these hospitals
consist of several hospital locations, organised together
under the same board and Chief Executive Ofﬁcer
(CEO). Eighteen participated in 2010 and 2013. All ﬁve
privately owned but publicly funded hospitals partici-
pated in 2010, 2012 and 2013, four in 2011. According
to the GTT standard methodology, discharges from
paediatric, psychiatric or rehabilitation units were
excluded. Patients had to be admitted to the hospitals
for more than 24 h, to be included.
TRANSLATION AND VALIDATION OF THE INSTRUMENT
The original GTT white paper was translated to
Norwegian by a professional translator. The professional
translation was validated by two clinical consultants
(attending) who read it through and gave feedback. It
was not back translated since it was considered a tool
and not a questionnaire. The translated version was
slightly modiﬁed by the campaign secretariat, regarding
these three triggers on the trigger list:
▸ A medication commonly used against allergic
reactions;
▸ The denomination used for blood glucose was
changed;
▸ A blood test commonly used to monitor anticoagula-
tion status.
Additional input for minor improvement of the trans-
lation came from record reviewers during the ﬁrst
months of the review in 2011. A protocol for how to
perform the GTT review in the Norwegian campaign
context was provided.16 It included a frequently asked
questions (FAQ) list corresponding to the Norwegian
context, in addition to the standard list.
Training and standardisation
GTT teams were trained according to the white paper
standard and this is further described in the online sup-
plementary appendix. The teams:
▸ Read the white paper and FAQ list before participat-
ing in the standardised 1-day course.
▸ Reviewed another 40 medical records before conduct-
ing regular reviews.
▸ Gathered at annual national meetings, to audit how
the tool was applied.
Standardisation nationally was promoted through the fol-
lowing rules:
▸ Hospitals were required to establish at least one GTT
team consisting of a doctor and two nurses.
▸ Each GTT team reviewed 240 medical records per
year, strictly according to the IHI method.
▸ All eligible hospital discharges had to be included in
the review.
▸ If there were more than one GTT team in a hospital,
each team would make a sample of 240 discharges
from different parts of the total population of eligible
discharges that could not overlap.
▸ Identiﬁed AEs were categorised according to the
severity categories E to I (description given in
table 1), which are standard according to the GTT
method, as well as type. GTT teams could not cat-
egorise AEs according to more than one severity.
Data reporting
The numbers of discharges with AEs, and AE severities
and types per speciﬁed discharge were reported in an
Excel template, which was annually sent to the campaign
secretariat. In addition, the teams reported the total
number of discharges that investigated records had been
randomly selected from. This number was used for
weighting the team results, when making national esti-
mates. National estimated AE rates were presented in a
Table 1 Estimated mean difference in adverse event
(AE) rates between 2013 and 2011 according to severity
(with description of severity categories for the AE)
Severity category
Mean difference
(95% CI)
E: AE contributed to temporary
harm to the patient which required
intervention
−2.6 (−3.4 to −0.4)*
F: AE contributed to temporary
harm to the patient which required
initial or prolonged hospitalisation
−0.9 (−1.7 to 1.0)
G: AE contributed to permanent
patient harm
−0.2 (−0.6 to 0.2)
H: intervention was required to
sustain life
−0.2 (−0.3 to −0.04)*
I: AE contributed to patient death 0.03 (−0.1 to 0.2)
E-I −3.4 (−4.0 to −0.5)*
F-I −1.3 (−2.0 to 0.6)
Mean difference in rates of AEs between 2013 and 2011,
computed by the mean of the pairwise differences in each
hospital. The lower and upper bounds of the 95% CI for the mean
of the hospital pairwise differences are given below the estimate
and are computed using 10 000 bootstrap simulations.
*Indicates a significant difference between the national AE rates in
2013 and 2011 at 5% significance level.
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national report as per cent discharges with at least one
AE in severity categories E to I compounded to E-I, and
F to I compounded to F-I, together with a 95% CI.15
Discharges with multiple AEs in different severity cat-
egories were reported in each of the different categories.
The compounding of the E-I and F-I categories took this
into account by not counting these discharges more
than once.
Ethics
Information that could be used to identify individual
patients, for example, age, gender and date of discharge,
were not reported, according to regulations for personal
protection.
Statistical analysis
Cross-sectional analysis was performed on data annually
reported in Excel templates from the GTT teams to cal-
culate national AE rates with associated 95% CIs,
divided into types and severities (table 1). Types of AEs
were not estimated in this study, but are reported else-
where.15 The national AE rates were calculated as a
weighted average of individual means for the GTT
teams from all hospitals. Since AEs according to type
and severity were not symmetrically distributed across
the GTT teams, non-parametric CIs for the national AE
rates were calculated using 10 000 bootstrap simula-
tions.17 The bootstrap was performed by sampling with
replacement from the individual means for all GTT
teams. An observation was drawn from the data with
probability equal to the weight of the GTT team. For all
analyses, p<0.05 was regarded as statistically signiﬁcant.
Microsoft Excel V.2010 was used for collecting and man-
aging the data, cross-sectional analysis and for producing
the graph. Bootstrap CIs, based on 10 000 simulations,
were calculated with the R statistical software.18
At local level, AE data were measured, registered and
plotted in run charts twice a month in Extranet by the
GTT teams. Data could also be exported to make
p-control diagrams providing analysis over the develop-
ment of AEs over time, both at local and national level.
Local p-control diagrams are not shown here. The
national p-control diagram is given in ﬁgure 1. The
chart was made based on bimonthly data registered in
Extranet and the national AE rate is calculated as a
weighted average of individual means for all GTT teams.
The number of GTT teams contributing to each data
point in the chart varied between 32 and 36, meaning
that not all of the GTT teams have registered data twice
a month in Extranet (39–47 teams did the annual
reviews, see table 2). Numbers of discharges reviewed at
each point varied between 7 and 20 for each team, and
between 320 and 381 at national level. The bimonthly
data from Extranet was only used to develop the
national p-control diagram; the rest of the analysis was
based on data annually reported from the GTT teams in
the Excel templates.
To explore the relation between size of hospitals and
AE rates for the severity categories E-I, a mixed-effect
model with the percentage of discharges with AEs as
response was ﬁtted. Year and the number of discharges
(used as a proxy for hospital size, reﬂecting hospital’s
workload) were included as ﬁxed effects, and hospital
was included as a random effect. The data were
weighted according to the proportion of medical
records that were sampled from each hospital. A 95%
bootstrap CI based on 10 000 simulations was used to
make inferences of the parameter of interest, the effect
of number of discharges. Model ﬁt was assessed using
the marginal R2 for mixed-effect models.19
To explore how the national AE rates and severity
develop over time, we looked at the differences between
Figure 1 Estimated per cent discharges with at least one adverse event (AE) in severity categories E-I across all hospitals,
2011–2013. The light blue dashed line shows AE rates over time, calculated as the weighted average of individual means for all
Global Trigger Tool (GTT) teams. The black smoothed line shows means of 10 consecutive dots. A red line marks the mean
level in 2011 (set as baseline from 2012 and onwards since several teams did not have complete data in 2010) with 95% CIs
marked with dashed red lines. The green line shows the linear trend. A regression of the AE rates against time shows a decline
in AEs for the whole period (p<0.001).
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the AE rates in 2013 and 2011. To control for the
dependence between hospitals at the two time points,
the pairwise differences in each hospital were used.
Ninety-ﬁve per cent CIs for the mean of the hospital
pairwise differences were calculated using 10 000 boot-
strap simulations (table 1). The analysis of the individual
severity categories were considered supplemental to the
analysis of the E-I and F-I categories. This is elaborated
in the discussion. Since the categories overlapped, usual
multiple comparison procedures, such as the Bonferroni
correction, were inappropriate.
RESULTS
In 2010, 85% of the country’s eligible discharges from
March to December were included in the hospital
teams’ sample frames. From 2011 and onwards, 98% or
more of eligible discharges were included in the study.
Table 2 shows annual estimates and 95% CIs of dis-
charges with at least one AE in severity categories E-I
and F-I from 2010 to 2013. These are the parameters
that were made public in annual reports.15 The table
also gives annual numbers of reviewed discharges,
numbers of discharges the records were randomly
selected from and number of reviewing GTT teams.
The estimates of discharges with at least one AE in
severity categories E-I show a signiﬁcant decrease from
2011 to 2012 (−2.4% (−4.5% to −0.3%)) and from 2011
to 2013 (−3.1% (−5.2% to −1.1%)). The decrease from
2012 to 2013 is not statistically signiﬁcant (−0.7%
(−2.7% to 1.2%)). The estimates of discharges with at
least one AE in severity categories F-I do not show any
statistically signiﬁcant decrease.
The model used to estimate the relation between size
of hospitals and AE rates had an acceptable ﬁt, with a
marginal R2 of 0.31. Estimated AE rates in severity cat-
egories E-I were reduced by 0.09 percentage points
(95% CI −0.15 to −0.04) for each 1000 additional dis-
charges, which we used as a proxy for hospital size.
As seen from table 1, estimated decline in national AE
rates from 2013 to 2011 was signiﬁcant for the severity
categories E, H and E-I when looking at the pairwise dif-
ferences in each hospital.
DISCUSSION
This study describes the variation in estimates of AEs in
Norwegian hospitals during a 4 years period obtained as
a result of national monitoring. To what extent could
the results be biased by the way the review was orga-
nised? The reviewers’ experiences from various special-
ties may have inﬂuenced their view on whether, for
example, an AE caused intermediate or permanent
harm. That could inﬂuence whether an AE was cate-
gorised as severity F or G. To reduce this potential for
bias, we constructed the compounded severity category
F-I. Although teams were trained in the same way
(except one hospital that had already started), they
could have varied in how carefully they examined the
medical records. Teams that spend more time on
reading nurse notes might ﬁnd more AEs in the
category E, than teams that read them more brieﬂy.
Such AEs could, for example, be mild decubitus ulcers
that only demanded some cream put on, or falls that
gave small bruises, only demanding adhesive plaster.
This could have inﬂuenced hospital results. To reduce
this potential for bias, we constructed the compounded
severity category E-I, and counted discharges with mul-
tiple AEs only once. Team adjustment of interpretation
and application of the GTT deﬁnitions and method
over time could have inﬂuenced the AE estimates and
contributed to the decline. Brian Bjørn in the Danish
society for patient safety has communicated to the
authors that in their experience AE rates of least severity,
in the E category, can be exposed to variability in the
teams application of the GTT deﬁnition over time. To
counter we had annual national gatherings where
Norwegian GTT teams audited cases and routines, to
synchronise and solidify their practices. The meetings
contributed to correction of occasional deviation in
practice, but did not reveal widespread changes in how
teams had applied the method and deﬁnitions. We can,
however, not be certain about this without scientiﬁc veri-
ﬁcation. The validity of our AE estimates is to some
extent conﬁrmed by that they correlate with patients
reported perceptions of patient safety surveyed in the
same hospitals.20
Table 2 Estimated discharges with at least one AE according to severity
2010 2011 2012 2013
Per cent discharges with at least one
AE in severity categories E-I (95% CI)
15.9 (13.8 to 17.8) 16.1 (14.6 to 17.5) 13.7 (12.5 to 15.1) 13.0 (11.7 to 14.2)
Per cent discharges with at least one
AE in severity categories F-I (95% CI)
8.9 (7.3 to 10.5) 8.8 (7.9 to 9.8) 7.7 (6.8 to 8.6) 7.6 (6.6 to 8.7)
Number of reviewed discharges 7849 10 288 11 728 10 986
Number of discharges the records
were randomly selected from
501 549* 585 648 593 046 569 714
Number of GTT teams 39 47 47 45
National AE rates from 2010 to 2013 with associated 95% CIs, divided into the severity categories E-I and F-I. From 2010 to 2013, 178 teams
reviewed in total 40 851 medical records randomly selected from 2 249 957 discharges.
*The review in 2010 only included the months from March until December.
AE, adverse event; GTT, Global Trigger Tool.
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The results indicate a decline in AEs in the com-
pounded category of E-I and in the category of least
severity, the E category. One could easily conclude that
the signiﬁcant decrease in the E category fully explains
the decrease in the E-I category. Non-signiﬁcant
decreases in the other severity categories as well, contra-
dict that. They can also contribute to the observed effect
in the E-I category. The E-I category is not just the sum
of the individual subcategories. One discharge with two
AEs in the E and G categories would only be counted
once in the E-I category, but twice in the individual sub-
categories, one in the E category and one in the G cat-
egory. The observed decline of AEs in the H category
could mean that fewer patients experienced severe AEs
requiring lifesaving intervention. We consider that the
result should be interpreted with caution since the CI is
near zero. When we explored the relation between
number of discharges in the hospitals and AE rates, we
found that hospitals with fewer discharges were more
likely to have slightly higher estimates of AEs than those
with many discharges. Causality between the decline in
AEs and the interventions of the national patient safety
campaign15 could not be inferred.
There was a public criticism in 2012 regarding why pos-
sible confounding effects of demographic characteristics,
like, for example, gender and age, had not been analysed.
Collection of demographic data had been prevented by
regulations regarding personal protection. In addition, it
had been considered that the risk for the sample to be
skewed regarding demographic characteristics was
minute since the random samples from each year in the
study were very large and had been drawn from more or
less all somatic hospital discharges in the country.
GTT may reveal risks that are not necessarily captured
by diagnosis-based quality registers. This is because the
GTT review is done regardless of the patients’ somatic
diagnosis. An additional value is that GTT supports plot-
ting results in run charts and control charts for local
monitoring, based on small data samples over time.
Other opportunities lie in adapting the GTT method, so
that its deﬁnitions of AEs are applied to more speciﬁc
clinical contexts, and exploring how AE rates can be used
for improvement purposes at hospital and clinical level.
The Norwegian patient safety campaign initiated
medical record review in all hospitals to monitor AE
rates. The idea was that the information could motivate
hospital CEO’s efforts to reduce risk for harming
patients, and that the monitoring could inform the
Norwegian Ministry of Health and Care Services in their
governing efforts. Since the GTT tool has facilitated the
Ministry to mandate 50% reduction in preventable AEs
over the next 5 years, it can be said to have succeeded as
a surveillance tool. But we have had little systematic
information about how CEOs have used the information
to monitor or improve patient safety at hospital level. It
is reported that clinicians get frustrated by the data,
because they mostly exist at hospital level, and therefore
are not relevant to evaluate interventions at clinical
level. To further expand understanding on how struc-
tural conditions and organisational culture inﬂuence AE
rates, AE estimates could be compared with surveys of
workplace environment and patient safety culture.
These are opportunities for future research.
CONCLUSIONS
The study describes a successful experience of monitor-
ing national estimates of AEs based on medical record
reviews in all hospitals. Estimated AE rates in the cat-
egory of least severity decreased signiﬁcantly during the
ﬁrst 2 years of the monitoring. Smaller hospitals had
slightly higher AE rates than larger hospitals.
Monitoring AE estimates emerges as a potential element
in national systems for patient safety.
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